Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Five Fractions Ultrahypofractionated Whole Breast Radiotherapy and Simultaneous Integrated Boost to the Tumor Bed, for Breast Cancer Patients With Unfavorable Characteristics

NCT07020780 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07020780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07020780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Five Fractions Ultrahypofractionated Whole Breast Radiotherapy and Simultaneous Integrated Boost to the Tumor Bed, for Breast Cancer Patients With Unfavorable Characteristics
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Recruiting
Start date
July 25, 2025
Completion date
June 30, 2035
Enrollment
458 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer